Synergistic antitumor effects of circularly permuted TRAIL with doxorubicin in triple-negative breast cancer
Circularly permuted TRAIL (CPT), a novel recombinant TRAIL mutant, is a potent antitumor agent. However, its efficacy in triple-negative breast cancer (TNBC) remains unclear. Treatment with CPT alone and in combination with doxorubicin (Dox) is explored for its effects on the proliferation and apopt...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
China Science Publishing & Media Ltd.
2023-08-01
|
| シリーズ: | Acta Biochimica et Biophysica Sinica |
| 主題: | |
| オンライン･アクセス: | https://www.sciengine.com/doi/10.3724/abbs.2023160 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|